Copyright
©The Author(s) 2025.
World J Transplant. Jun 18, 2025; 15(2): 101005
Published online Jun 18, 2025. doi: 10.5500/wjt.v15.i2.101005
Published online Jun 18, 2025. doi: 10.5500/wjt.v15.i2.101005
Table 6 Studies describing amiodarone use in atrial arrhythmias following lung transplantation, n (%)
Ref. | Year | Study type | Atrial fibrillation patients | Amiodarone use | Notes |
Magnusson et al[53] | 2022 | Case series | 159 | 63 (40) | Amiodarone increase mortality but not chronic lung allograft dysfunction |
Hathaway et al[43] | 2021 | Case series | 102 | 77 (79) | No difference between amiodarone and others. Safe to use |
Kim et al[44] | 2020 | Case series | 46 | 6 (13) | No mention of any amiodarone related adverse effect |
Barnes et al[45] | 2020 | Case control study | 100 | 48 (alone), 26 (combination) | Recommend amiodarone as the first drug to be used |
Malik et al[34] | 2013 | Case series | 27 | 24 (88.9) | No mention of any amiodarone related adverse effect |
Isiadinso et al[35] | 2011 | Case series | 62 | 38 (65) | 24 out of 38 (64%) of patients treated with amiodarone died |
Diaz-Guzman et al[81] | 2009 | Case report | 1 | 1 patient | Amiodarone pulmonary toxicity–resolved with cessation and steroids |
- Citation: Sunder T, Ramesh P, Kumar M. Atrial arrhythmias following lung transplantation: A state of the art review. World J Transplant 2025; 15(2): 101005
- URL: https://www.wjgnet.com/2220-3230/full/v15/i2/101005.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i2.101005